FDA Approves Moderna's Next-Generation COVID-19 Vaccine for Adults 65+
TL;DR Summary
The FDA has approved Moderna's new COVID-19 vaccine, mNEXSPIKE, for adults 65+ and those 12-64 with underlying conditions, marking the first approval under stricter standards requiring more studies, and signaling a shift in vaccine recommendations for healthy children and pregnant women.
- FDA approves new Moderna COVID-19 vaccine Axios
- US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older Reuters
- FDA approves a next-generation Covid vaccine from Moderna, with restrictions statnews.com
- Moderna Wins Narrower US Approval for New Covid Vaccine Bloomberg
- Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE USA Today
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
1 min
vs 2 min read
Condensed
88%
331 → 41 words
Want the full story? Read the original article
Read on Axios